Therapeutic Solutions International Announces Clinical Proof of Concept of Nanoparticle Pterostilbene Formulation: NanoStilbene™

Tucson News Now, 02 Jul 2018

Early Clinical Trial Data Supports Enhanced Biodistribution of NanoStilbene™ Compared to Standard Pterostilbene When Orally…

Therapeutic Solutions International Announces Clinical Proof of Concept of Nanoparticle Pterostilbene Formulation: NanoStilbene™

Benzinga, 02 Jul 2018

Early Clinical Trial Data Supports Enhanced Biodistribution of NanoStilbene™ Compared to Standard Pterostilbene When Orally…

Therapeutic Solutions International Announces Clinical Proof of Concept of Nanoparticle Pterostilbene Formulation: NanoStilbene™

Biz Wire Express, 02 Jul 2018

GlobeNewswire 2018-07-02 Early Clinical Trial Data Supports Enhanced Biodistribution of NanoStilbene ™ Compared to Standard…

Therapeutic Solutions International Announces Clinical Proof of Concept of Nanoparticle Pterostilbene Formulation: NanoStilbene™

NASDAQ, 02 Jul 2018

Early Clinical Trial Data Supports Enhanced Biodistribution of NanoStilbene™ Compared to Standard Pterostilbene When Orally…

Therapeutic Solutions Receives Allowance on Patent Claim from the US Patent Office Covering ProJuvenol(R) Active Ingredient Pterostilbene in Cancer Immunotherapies

EIN Newsdesk, 06 Feb 2017

/ EINPresswire.com / -- OCEANSIDE, CA --(Marketwired - February 06, 2017) - Therapeutics Solutions International, Inc., (OTC…

Therapeutic Solutions Receives Allowance on Patent Claim from the US Patent Office Covering ProJuvenol(R) Active Ingredient Pterostilbene in Cancer Immunotherapies - Press Release

Digital Journal, 06 Feb 2017

OCEANSIDE, CA --(Marketwired - February 06, 2017) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced…

Therapeutic Solutions Receives Allowance on Patent Claim from the US Patent Office Covering ProJuvenol(R) Active Ingredient Pterostilbene in Cancer Immunotherapies

Wall Street Online Denmark, 06 Feb 2017

) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today that the United States Patent and Trademark…

News story from Finanz Nachrichten on Monday 06 February 2017

Finanz Nachrichten, 06 Feb 2017

Therapeutic Solutions Receives Allowance on Patent Claim from the US Patent Office Covering ProJuvenol(R) Active Ingredient Pterostilbene in Cancer Immunotherapies

Yahoo! Finance USA, 06 Feb 2017

) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today that the United States Patent and Trademark…

Therapeutic Solutions Receives Allowance on Patent Claim from the US Patent Office Covering ProJuvenol(R) Active Ingredient Pterostilbene in Cancer Immunotherapies

Yahoo! Finance USA, 06 Feb 2017

) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today that the United States Patent and Trademark…

Therapeutic Solutions Receives Allowance on Patent Claim from the US Patent Office Covering ProJuvenol(R) Active Ingredient Pterostilbene in Cancer Immunotherapies

NASDAQ, 06 Feb 2017

OCEANSIDE, CA -- (Marketwired) -- 02/06/17 -- Therapeutics Solutions International, Inc., (OTC PINK:TSOI) Proleukin® is one of…

Therapeutic Solutions Receives Allowance on Patent Claim from the US Patent Office Covering ProJuvenol(R) Active Ingredient Pterostilbene in Cancer Immunotherapies

Bioportfolio, 06 Feb 2017

OCEANSIDE, CA --(Marketwired - February 06, 2017) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced…